FDA Inspection 1190843 — Shady Grove Reproductive Science Center PC

Shady Grove Reproductive Science Center PC — FEI 3005667811

The FDA completed an inspection of Shady Grove Reproductive Science Center PC on November 4, 2022 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 4, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Washington, DC (United States)